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Abstract Objective: To assess hearing functions in pediatric 
patients with selective immunoglobulin A (IgA) de-
ficiency (SIGAD).
Methods: Pure-tone audiometry, acoustic impedance, 
otoacoustic emission, and brainstem audiometric me-
asurements were taken during a non-infectious period 
in 28 patients with SIGAD and 28 healthy children 
with normal otoscopic examination. The results of the 
hearing tests were compared between the two groups.
Results: Two male patients and one female patient in 
the SIGAD group were found to have sensorineural 
hearing loss (SNHL). However, a comparison of the 
average pure tone cut-off values at 0.5, 1, 2, and 4 kHz 
did not reveal any statistically significant difference 
between the groups (p>0.05).
Conclusion: Pediatric patients with SIGAD may 
exhibit SNHL at certain frequencies and require 
follow-up for the potential development of hearing 
loss.
Keywords: Sensorineural hearing loss, primary im-
munodeficiency, pediatric, selective IgA deficiency
Introduction
Selective immunoglobulin A (IgA) deficiency 
(SIGAD) is defined as a serum IgA level of less 
than 7 mg/dl in children over 4 years of age with 
normal immune system. SIGAD may be partial 
or complete and may represent the most com-
mon form of primary immune deficiencies, with 
an average prevalence between 1/143 to 1/18500 
per population (1). Patients with SIGAD gen-
erally have an increased risk of sinopulmonary 
infections, allergy, and auto-immune conditions. 
Arnold et al. (2), using immunohistochemical 
methods, confirmed the presence of IgA and 
IgG in the epithelial cells of the inner ear and in 
the lumen of the endolymphatic sac of healthy 
individuals. Moreover, inflammatory conditions 
have been found to be associated with increased 
IgA levels in the endolymphatic sac (3).
Several immune disorders have been shown to 
occur in adults with autoimmune sensorineural 
hearing loss (4, 5). Furthermore, patients with 
X-linked agammaglobulinemia (XLA) and 
common variable immune deficiency (CVID) 
have been shown to suffer from sensorineural 
hearing loss (SNHL) (6, 7).
Patients with SIGAD are more susceptible to 
recurrent infections, especially acute otitis me-
dia. Hearing loss caused by recurrent infections 
may frequently occur in these patients. Howev-
er, there are very few studies examining the fre-
quency of SNHL in patients with SIGAD. In 
this study, our objective was to assess the func-
tions of the inner ear in patients with SIGAD.
Methods
This study was performed at Başkent University, 
with the support of the Research Council of the 
School of Medicine at Başkent University and 
with the approval of the local ethics committee 
(Project No: KA 17/02). Patients with a diagno-
sis of SIGAD followed up at the Immunology 
department were included in this study based on 
the following inclusion criteria:
1- Serum IgA <7 mg/dL
2- Normal serum IgG and IgM
3- Absence of Ig prophylaxis
4- Absence of acute or chronic ear conditions
5- Normal screening test results during the newborn period
6- Absence of a family history of SNHL
Patients with a history of premature birth, low birth weight, 
hyperbilirubinemia, systemic conditions, ototoxic medica-
tions, or acoustic trauma were excluded. Informed consent 
was obtained from the parents of the patients.
Otoscopy results were found to be normal in all patients. The 
following tests were performed during a non-infectious pe-
riod: pure-tone audiometry, acoustic impedance, otoacoustic 
emission, and brainstem audiometry. A bone threshold level 
greater than 20 dB at any frequency was considered to in-
dicate the presence of SNHL. Cochlear and retrocochle-
ar SNHL were differentiated, and those with retrocochlear 
hearing loss were excluded from the study. Alterations in 
hearing functions in these cases were recorded and compared 
with those in the healthy pediatric control group. Data anal-
ysis was performed using Statistical Package for the Social 
Sciences 17.0 software pack (SPSS Inc.; Chicago, IL, USA). 
Audiometry results were compared using the chi-square test, 
and all tests were performed at a significance level of 0.05.
Results
A total of 28 children with SIGAD and 28 healthy controls 
were included in this study. The demographic characteristics 
of the patients are summarized in Table 1. The groups were 
compared in terms of age and gender distribution.
The pure-tone audiometric examination revealed the pres-
ence of unilateral SNHL in two male patients and bilateral 
SNHL in one female patient (Table 2).
A comparison between the groups with regard to the average 
pure-tone thresholds did not reveal any significant difference 
at 0.5, 1, 2, and 4 kHz (Table 3).
Discussion
The increased frequency of recurrent upper respiratory tract 
infections as well as ear infections in patients with SIGAD 
has been clearly documented previously (8). Moreover, the 
increased levels of IgA in the epithelial cells of the inner ear 
and in the endolymphatic sac has been demonstrated, with 
inflammatory conditions. Obviously, these represent a com-
ponent of the immune response. Thus, patients with SIGAD 
are more likely to experience weakened immune responses in 
the inner ear with a subsequent increase in the risk of hear-
ing loss. In the present study, audiometric examinations were 
performed in patients with SIGAD. One female patient had 
bilateral SNHL of 25 dB at 500 and 1000 Hz, whereas one 
male patient had unilateral SNHL of 25 dB at 2000-4000 
Hz and another male patient had unilateral SNHL of 30 dB 
at 250-500 Hz.
In the study by Berlucchi et al. (6) that examined a total of 25 
patients with XLA using audiometry, seven patients (28%) 
were found to have SNHL. However, all patients with XLA 
included in that study had Bruton Tyrosine Kinase gene mu-
tations, as well as a past history of meningoencephalitis in 
two patients, Arnold-Chiari malformation in one, and po-
lio-myelitis in one patient. In a study by Midilli et al. (7) 
that involved a total of 13 patients with CVID, SNHL was 
found to be present at higher frequencies (>8 kHz), although 
they concluded that further comparative studies in larger 
sample populations are warranted for better elucidation of 
their results. In a previous study comparing patients with au-
toimmune SNHL and healthy adult controls, significant re-
ductions in IgG1 and IgG3 serum levels were found. In that 
study, however, serum IgA levels were also compared and no 
significant differences were observed (4).
In adult patients with SNHL, autoimmune processes have 
been implicated in the etiology of this condition. However, 
autoimmune processes are extremely complex, with no clear-
cut results from efforts to develop reasonable models (9). IgA 
plays a role in the integration of systemic and mucosal immune 
responses, and its deficiency is associated with an increased 
frequency of several autoimmunological conditions, including 
hemolytic anemia, thrombocytopenic purpura, and juvenile 
rheumatoid arthritis (8). Moreover, weakened IgA respons-
es may represent a part of the immune reactions that occur 
during the process leading to the development of hearing loss.
A majority of pediatric SNHL cases are congenital, which 
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Table 1. Demographic data of the study groups
 SIGAD Controls
Number of subjects 28 28
Gender (M/F) 15/13 16/12
Age 5-15 (mean 7.6) 4-16 (mean, 8.1)
SIGAD: selective IgA deficiency; M: male; F: female
Table 2. Results of hearing tests among patients with selective IgA 
deficiency
 Bilateral SNHL  Unilateral SNHL 
Number of patients with SNHL 1 (3, 57%) 2 (7, 14%)
SNHL frequency 500-1000 Hz 2000-4000 Hz 
  250-500 Hz
SNHL level 25 dB 25 and 30 dB
SNHL: sensorineural hearing loss; Hz: Hertz; dB: decibel
Table 3. Average hearing thresholds for the study subjects
 0,5 kHz 1 kHz  2 kHz 4 kHz 
SIGAD 18 dB 21 dB 20 dB 22 dB
Controls 15 dB 19 dB 18 dB 17 dB
p>0.05    
SIGAD: selective IgA deficiency; Hz: Hertz; dB: decibel
may be readily detected using screening methods during 
the newborn period (10). In our study, patients with con-
genital SNHL were excluded based on the results of oto-
acoustic emission tests performed during the newborn pe-
riod. Other causes of SNHL include the use of ototoxic 
medications and acoustic trauma, which lead to SNHL at 
higher frequencies (>4 kHz) (11). No patients in our study 
were found to have hearing loss above the frequency of 4 
kHz as confirmed using otoacoustic emission and brain-
stem audiometric tests.
Selective IgA deficiency is associated with recurrent boots of 
upper respiratory tract and ear infections. Repetitive courses 
of upper respiratory tract infections due to viruses and ear 
infections may result in the development of hearing loss. In 
the present study, three patients were found to have SNHL 
at limited frequencies. A major limitation of our study, sim-
ilar to other conditions of the inner ear, was our inability to 
perform a comparison between our findings and histopatho-
logical characteristics of the inner ear, with a consequent ab-
sence of information on the histopathological aspects of the 
condition. Several electrophysiological measurements were 
taken to compensate for this lack of histopathological find-
ings. Other limitations include the small sample size and the 
cross-sectional nature of the study. Such factors might have 
decreased the statistical significance of our results. Further 
studies involving larger patient populations and longer fol-
low-up periods may better delineate the effect of SIGAD on 
inner ear functions.
Conclusion
Pediatric patients with SIGAD may experience SNHL at 
certain frequencies. An association between these two con-
ditions may be better defined with the involvement of high-
er number of patients with recurrent middle-ear infections 
followed up for longer durations. Moreover, examination of 
the development of autoimmune SNHL in pediatric patients 
with SIGAD may shed further light on the pathogenesis of 
this condition.
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